Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukemia, High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Testing effectiveness (Phase 2)Study completedNCT00002831
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 24
Early research (Phase 1)Study completedNCT04840875
What this trial is testing

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00002865
What this trial is testing

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)UnknownNCT01484171
What this trial is testing

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT03030612
What this trial is testing

ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
OncoVerity, Inc. 38
Post-approval studies (Phase 4)Looking for participantsNCT07016165
What this trial is testing

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Who this might be right for
Neutropenic FeverAcute Lymphoblastic LeukemiaAcute Myeloblastic Leukemia+1 more
Gadjah Mada University 120
Testing effectiveness (Phase 2)Study completedNCT00531232
What this trial is testing

A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid Leukemia (AML)
Genzyme, a Sanofi Company 38
Not applicableEnded earlyNCT00967525
What this trial is testing

Intraosseous Infusion of Unrelated Cord Blood Grafts

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+1 more
Emory University 5
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Testing effectiveness (Phase 2)Study completedNCT00569010
What this trial is testing

Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 36
Early research (Phase 1)Ended earlyNCT04477291
What this trial is testing

CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Aptose Biosciences Inc. 45
Large-scale testing (Phase 3)Study completedNCT01015196
What this trial is testing

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 832
Testing effectiveness (Phase 2)Study completedNCT01238211
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT07199855
What this trial is testing

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University 24
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT01567059
What this trial is testing

Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Multilineage DysplasiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more
Fred Hutchinson Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT00002945
What this trial is testing

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 61
Testing effectiveness (Phase 2)Ended earlyNCT02152956
What this trial is testing

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Who this might be right for
AML
MacroGenics 244
Next Page